Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 23 Oct 2019 – 20 Aug 2026, limited by Axis Nifty 100 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty 100 Index Fund | Nifty 100 |
|---|---|---|
| 23 Oct 2019 | ₹100.00 | ₹100.00 |
| 18 May 2020 | ₹76.91 | ₹76.55 |
| 12 Dec 2020 | ₹115.96 | ₹116.03 |
| 07 Jul 2021 | ₹136.65 | ₹137.02 |
| 31 Jan 2022 | ₹148.62 | ₹149.18 |
| 27 Aug 2022 | ₹152.37 | ₹152.13 |
| 23 Mar 2023 | ₹143.92 | ₹144.17 |
| 16 Oct 2023 | ₹167.24 | ₹167.32 |
| 11 May 2024 | ₹194.68 | ₹194.76 |
| 05 Dec 2024 | ₹218.31 | ₹218.13 |
| 01 Jul 2025 | ₹222.97 | ₹222.37 |
| 24 Jan 2026 | ₹218.04 | ₹217.39 |
| 20 Aug 2026 | ₹205.91 | ₹215.87 |
| Metric | Axis · Regular · IDCW NAV ₹20.51 Very High risk ★★★☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -6.17% | +4.72% | |
| +7.98% | +7.52% | |
| +7.84% | +8.28% | |
| — | +9.00% | |
| +11.16% | +7.27% | |
| +5.79% | — | |
| +14.57% | +7.88% | |
| +14.54% | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 13.81% | 13.54% | |
| 0.11 | 0.11 | |
| 0.14 | 0.15 | |
| -37.19% | -15.67% | |
| Nifty 100 | — | |
| -1.73% | -0.05% | |
| 1.09 | 1.00 | |
| 100.5% | 101.3% | |
| 111.9% | 99.5% | |
| 0.97% | 0.88% | |
| ₹1,973Cr | ₹181.49Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 5% | 38% | |
| Karthik Kumar | — | |
| 23 Oct 2019 | — | |
| 100 | — | |
| 43.7% | — | |
| 0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.